Cargando…

Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer

We attempted to investigate immunohistochemical expression of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), platelet-derived growth factor (PD-ECGF), c-erbB-2, matrix metalloproteinase-2 (MMP-2), and MMP-9 using surgical specimens of 119 non-small-cell lung carcin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shou, Y, Hirano, T, Gong, Y, Kato, Y, Yoshida, K, Ohira, T, Ikeda, N, Konaka, C, Ebihara, Y, Zhao, F, Kato, H
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363988/ https://www.ncbi.nlm.nih.gov/pubmed/11742492 http://dx.doi.org/10.1054/bjoc.2001.2137

Ejemplares similares

Phosphorylated tyrosine-containing proteins in primary lung cancer correlates with proliferation and prognosis
por: Gong, Y, et al.
Publicado: (2002)

Comparison of endoscopic features of early-stage squamous cell lung cancer and histological findings
por: Konaka, C, et al.
Publicado: (1999)

Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma
por: Kikuchi, R, et al.
Publicado: (2000)

Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin
por: Varani, J, et al.
Publicado: (2000)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003)

The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells
por: Rooprai, H K, et al.
Publicado: (2000)

Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression
por: Hofmann, U B, et al.
Publicado: (1999)

Endoscopic Diagnosis and Treatment of a Case of Respiratory Papillomatosis
por: Hirano, T., et al.
Publicado: (1997)

Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissuenhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase
por: Collins, H M, et al.
Publicado: (2001)

Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1
por: Suminami, Y, et al.
Publicado: (2000)

Matrix metalloproteinases (MMPs) in fresh human prostate tumour tissue and organ-cultured prostate tissue: Levels of collagenolytic and gelatinolytic MMPs are low, variable and different in fresh tissue versus organ-cultured tissue
por: Varani, J, et al.
Publicado: (2001)

Elevated Expression of Matrix Metalloproteinase-9 not Matrix Metalloproteinase-2 Contributes to Progression of Extracranial Arteriovenous Malformation
por: Wei, Ting, et al.
Publicado: (2016)

Early Localization of Bronchogenic Cancerous/Precancerous Lesions With Lung Imaging Fluorescence Endoscope
por: Ikeda, N., et al.
Publicado: (1997)

Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer
por: Sato, F, et al.
Publicado: (1999)

Early Detection of Bronchial Lesions Using Lung Imaging Fluorescence Endoscope
por: Ikeda, N., et al.
Publicado: (1999)

Angiogenetic Factors in Chronic Subdural Hematoma Development
por: Petrov, Andrey, et al.
Publicado: (2022)

Diuretic response to cyclophosphamide in rats bearing a matrix metalloproteinase-9-producing tumour.
por: Mizushima, Y., et al.
Publicado: (1998)

Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma
por: Wang, Bin, et al.
Publicado: (2018)

Transcriptional dysregulation of the p73L / p63 / p51 / p40 / KET gene in human squamous cell carcinomas: expression of Δ Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumour suppressor p51
por: Senoo, M, et al.
Publicado: (2001)

The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation
por: Paju, A, et al.
Publicado: (2001)

RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer
por: Oshikiri, T, et al.
Publicado: (2001)

Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts
por: Sato, T, et al.
Publicado: (1999)

Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma.
por: Kim, T. S., et al.
Publicado: (1999)

Inhibition of angiogenetic macrophages reduces disc degeneration-associated pain
por: Hou, Yang, et al.
Publicado: (2022)

Vesnarinone and glucocorticoids cooperatively induce G(1) arrest and have an anti-tumour effect on human non-small cell lung carcinoma cells grown in nude mice
por: Honma, Y, et al.
Publicado: (1999)

Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases
por: Yamada, Hiroshi, et al.
Publicado: (2016)

Monitoring gastric cancer progression with circulating tumour DNA
por: Hamakawa, T, et al.
Publicado: (2015)

Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis
por: Tsukifuji, R, et al.
Publicado: (1999)

Matrix Metalloproteinase-2 Activated by Ultraviolet-B Degrades Human Ciliary Zonules In Vitro
por: Shiroto, Yuki, et al.
Publicado: (2021)

Inflammatory cell-mediated tumour progression and minisatellite mutation correlate with the decrease of antioxidative enzymes in murine fibrosarcoma cells
por: Okada, F, et al.
Publicado: (1999)

Remodeling Factors, Transcription Factors and Angiogenetic Factors in Cholesteatoma in Ontogenetic Aspect
por: Dambergs, Kristaps, et al.
Publicado: (2022)

Relationship between matrix metalloproteinases and the occurrence and development of ovarian cancer
por: Zhang, Y., et al.
Publicado: (2017)

Relationship between TA01 and TA02 polypeptides associated with lung adenocarcinoma and histocytological features.
por: Hirano, T., et al.
Publicado: (1997)

Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression
por: Gong, Yixuan, et al.
Publicado: (2014)

Down-regulation of Fas-L in glioma cells by ribozyme reduces cell apoptosis, tumour-infiltrating cells, and liver damage but accelerates tumour formation in nude mice
por: Chio, C-C, et al.
Publicado: (2001)

Genomic variations within matrix metalloproteinase-9 and severe sepsis
por: Chen, Q, et al.
Publicado: (2009)

Mammographic Density and Matrix Metalloproteinases in Breast Tissue
por: Steude, Jana S., et al.
Publicado: (2009)

Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway
por: Ueoka, Y, et al.
Publicado: (2000)

Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negativeatients
por: Scorilas, A, et al.
Publicado: (2001)

Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart
por: Klopsch, Christian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_voejk5ghijpvbmh3jc7a3v9o05